Hydroxychloroquine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Condition:   Systemic Lupus Erythematosus Interventions:   Biological: Telitacicept;   Drug: Hydroxychloroquine;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Cyclophosphamide;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus Sponsor:   Fen Li Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2022 Category: Research Source Type: clinical trials